盘龙药业：注销用于中药项目的募集资金专户

Core Viewpoint - The company announced a private placement of 9.35 million shares at a price of 32.29 yuan per share, raising a total of 302 million yuan, with a net amount of 295 million yuan [1] Group 1: Fundraising Details - The company signed a tripartite supervision agreement with the sponsoring institution and related banks regarding the raised funds [1] - The funds are designated for the "Research and Industrialization Project of Traditional Chinese Medicine Formula Granules" [1] Group 2: Account Status - As of the announcement date, the account at Bank of China Xi'an Software Park Branch for the project has a zero balance and will be closed in 2026, with the corresponding supervision agreement also terminating [1]